UCLA Fast Neuro helps keep patients with nonemergent neurologic complaints out of the emergency department
This normally uncommon type of immune system cell can safely and effectively destroy SARS-CoV-2
UCLA’s Dr. Joshua G. Cohen is the principal investigator on a multi-campus study launching in the spring
The CRISPR-based method could restore the muscle protein missing in patients with a degenerative neuromuscular disease
While one twin went plant-based, the other favored meat, fish, and dairy; In the end, they both saw changes in their body.
‘Immunotherapy effectively has given a fourth pillar of cancer therapy besides surgery, radiation therapy and chemical therapy,’ said UCLA Health’s Dr. Antoni Ribas
Findings could help researchers understand why the disease progresses faster in some patients than others
Ovarian cancer is the leading cause of gynecologic cancer death in the U.S.
Study was published Dec. 28 in Cell Reports